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We report a novel mutation in the exon 6 splice
donor site of keratin 1 (G4134A) that segregates with
a palmoplantar keratoderma in three kindreds. The
nucleotide substitution leads to the utilization of a
novel in-frame splice site 54 bases downstream of the
mutation with the subsequent insertion of 18 amino
acids into the 2B rod domain. This mutation appears
to have a milder effect than previously described
mutations in the helix initiation and termination
sequence on the function of the rod domain, with
regard to ®lament assembly and stability. Affected
individuals displayed only mild focal epidermolysis
in the spinous layer of palmoplantar epidermis, in
comparison with cases of bullous congenital ichthyo-
siform erythroderma also due to keratin 1 mutations,
which show widespread and severe epidermolysis.
This study describes a novel mutation in KRT1 that
results in a phenotype distinct from classical bullous
congenital ichthyosiform erythroderma. Key words:
intermediate ®laments/keratin genes/rod domain. J Invest
Dermatol 116:606±609, 2001
T
he palmoplantar keratodermas (PPKs) are a highly
heterogeneous group of diseases that present as
thickening of the palmoplantar epidermis. These
disorders have previously been classi®ed according to
their phenotypic characteristics. The diffuse PPKs
show uniform thickening of the skin on the palms and soles,
compared to the different patterns of keratoderma seen in focal and
punctate PPK. The two simple forms of diffuse PPK are
epidermolytic PPK (EPPK: OMIM 144200) and nonepidermolytic
PPK (NEPPK: OMIM 148400) (Hatsell and Kelsell, 2000). These
two disorders are particularly dif®cult to separate when using only
clinical ®ndings. Histologically they differ, however, with EPPK
showing epidermolysis of keratinocytes in the suprabasal layers, a
characteristic not observed in NEPPK. In mild cases of EPPK,
however, diagnosis can still be problematic as detection of
epidermolysis can be dif®cult.
The genetic background of EPPK has been well studied since the
®rst identi®ed mutation in the palmoplantar speci®c keratin 9 (Reis
et al, 1994). EPPK has so far been shown to be a homogeneous
disease, with KRT9 mutations identi®ed in the majority of patients
investigated. The genetic basis of diffuse NEPPK is less well
described, with only one mutation being identi®ed in KRT1 as yet
(Kimonis et al, 1994). Other families with diffuse NEPPK have
been mapped outside the keratin cluster on 12q13, implying a non
keratin background to the disease in several families from Sweden
and the U.K. (Kelsell et al, 1999).
Keratins constitute the intermediate ®lament proteins of
keratinocytes. Type I and type II keratins form speci®c hetero-
dimers that are expressed in a differentiation and tissue speci®c
manner (Moll et al, 1982). Many epidermal diseases have been
associated with keratin mutations, which are proposed to disrupt
the cytoskeleton of the cell leading to collapse of the cell and loss of
adhesion (Corden and McLean, 1996).
The majority of KRT1 mutations have been identi®ed in bullous
congenital ichthyosiform erythroderma (BCIE). Speci®c mutations
in keratin 1, however, have been implicated in disorders with
different phenotypes. Here we describe three Scottish families in
which a mild epidermolytic diffuse PPK segregates with micro-
satellite markers mapping to the type II keratin cluster on 12q13.
Following the elucidation of the correct genomic structure of
KRT1, a novel mutation in the 2B rod domain causing the
insertion of 18 amino acids into the protein was detected in these
families. This adds to the evidence that KRT1 mutations can result
in a heterogeneous phenotype.
MATERIALS AND METHODS
Haplotype analysis using microsatellite markers Microsatellite
analysis was performed by polymerase chain reaction (PCR), using one
32P end-labeled and one unlabeled primer. The primer was labeled with
0.25 mCi (g-32P)-dATP per pmol primer and T4 polynucleotide kinase.
Genomic DNA (15 ng) was added to each PCR reaction, together with
1±5 pmol of each primer, 100 mM dNTP, Taq DNA polymerase buffer,
and 0.15 units Taq DNA polymerase (Life Technologies, Gibco, Paisley,
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U.K.). The PCR program was one cycle of 95°C for 4 min, 55°C for
30 s, 72°C for 30 s, and then 95°C for 30 s, 55°C for 30 s, 72°C for
30 s during 26 cycles, followed by 95°C for 30 s, 55°C for 30 s, 72°C
for 4 min. The PCR products were separated on 6% denaturing
polyacrylamide gels and detected by autoradiography.
For further haplotype analysis between families, microsatellite markers
were ampli®ed by PCR with M13 tagged forward primers and a third
M13 ¯uorescently labeled primer using standard cycling conditions.
Products were visualized and analyzed using an LI-COR 4200
GeneReadIR automated sequencer (MWG, Milton Keynes, U.K.).
Electron microscopy A biopsy sample of clinically affected skin was
processed for electron microscopy as described previously (Ishida-
Yamamoto et al, 1992) with few modi®cations. Brie¯y, the samples were
®xed ®rst in phosphate-buffered gluteraldehyde/formaldehyde ®xative,
then in aqueous osmium tetroxide, dehydrated in ethanol, and embedded
in epoxy resin (Taab Laboratories, Aldermaston, Berkshire, U.K.).
Semithin sections were cut and stained with methylene blue and azure II
for light microscopy and orientation purposes. Ultrathin sections were
stained with lead citrate and uranyl acetate and viewed in a JEOL 100
CX transmission electron microscope, operating at 80 kV. Sections of
normal epidermis were examined for comparative purposes.
Mutation detection The keratin 1 gene was ampli®ed from genomic
DNA using intronic primers (Table I), with conditions of 35 cycles of
95°C for 30 s, 60°C for 30 s, 72°C for 1 min, to obtain the full exonic
sequence. PCR fragments were directly sequenced using the same
primers.
Reverse transcriptase PCR (RT-PCR) RT-PCR was performed on
total RNA extracted from a snap-frozen skin biopsy obtained from an
affected individual using RNAzol, following the manufacturer's protocol
(Biogenesis, Poole, U.K.). PCR products, using primers spanning exons
2±7, were ampli®ed using GeneAmp RNA PCR kit (Perkin Elmer,
Warrington, U.K.). These were subcloned using a Topo TA cloning kit
(Invitrogen, Groningen, The Netherlands) and positive clones were
sequenced.
RESULTS
Clinical description of families Three Scottish pedigrees were
studied, in which autosomal dominant inherited PPK was
segregating. Two families were from Glasgow, and although no
relationship was identi®ed after 1830, their antecedents at this
period shared an unusual surname, suggesting an earlier common
ancestry. The third pedigree, from Ayrshire, was not known to be
related. Affected family members displayed hyperkeratosis restricted
to the palms and soles, but varying in severity, which had been
present since childhood (Fig 1). In the most severely affected cases,
there was con¯uent plantar keratoderma on weight-bearing
surfaces, but sparing the instep. Also in severe cases, the edge of
the normal skin bordering the keratoderma displayed a violaceous
erythema. In milder cases there was patchy plantar keratoderma in
Table I. Primer sequences for ampli®cation of all exons of
keratin 1
Exons ampli®ed Primer sequence 5¢±3¢
Exon 1 1F- ctgactctagaagaccaagc
1R- actgcaccgatcccgagtgg
Exon 2 2F- ctccatggctatgagactcc
2R- catgctgcttcatgatcttagc
Exons 3±4 3F- ttagaatgctggacttcagg
4R- tctagatcgttgtgggttcc
Exons 5±6 5F- ggactgcttctctgtctaag
6R- gaaagcactcgccctttacc
Exons 7±9 7F- tattggcctcactggagtgg
9R- atccaggttagacagagccg
Exon 8 sequencing primer 8F- ggttaagtgcatggggaggc
Figure 1. Clinical presentation of the disease, showing a diffuse
keratoderma restricted to the palms and soles.
Figure 2. Electron microscopy shows early cytolysis in an
epidermal keratinocyte. The nucleus (N) of a cell in the spinous layer
of a patient with a KRT1 mutation has an irregular, notched surface and
the perinuclear cytoplasm (CY) lacks the normal complement of
tono®laments. Tono®lament aggregates are present at the cell periphery,
where they appear to associate with desmosomes (arrows). Scale bar: 2 mm.
Figure 3. Affected individuals in pedigree 1 show a common
haplotype for microsatellite markers spanning the type II keratin
cluster on 12q13.
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weight-bearing areas, resembling focal keratoderma. Con¯uent
palmar keratoderma was seen only in manual workers, and even
then was the exception; most cases had patchy keratoderma of the
palmar midlines of the ®ngers and of pressure areas of the palm.
There was no generalized transgradient keratoderma, but several
individuals had developed marked local callosities on dorsal toes or
®ngers at sites of rubbing. The remaining skin looked entirely
normal except for mild hyperkeratosis of the knees in one man.
Nails, hair, and teeth were also normal, but another man
complained of rapidly growing cuticles of the nailfolds.
Electron microscopy Although epidermolysis had not been
identi®ed by light microscopy in biopsies from three individuals,
electron microscopy show that a minority of keratinocytes in the
spinous and granular layers appeared to be undergoing cytolysis.
The nuclei of affected cells had infolded nuclear membranes and
the perinuclear cytoplasm was largely devoid of tono®laments.
Instead, the tono®laments formed tight clumps or aggregates at the
cell surface, often adjacent to desmosomes. These changes did not
appear to affect clusters of adjacent cells, so the changes were less
disruptive than those typically seen in bullous congenital
ichthyosiform erythroderma (epidermolytic hyperkeratosis) where
blistering is associated with extensive cell lysis (Fig 2).
Haplotype analysis The chromosomal regions harbouring the
type I keratins on 17p21±q12 and type II keratins on 12q13 were
investigated in pedigree 1, using microsatellite markers mapping to
these regions. Six affected individuals from three generations of the
family were screened. A common haplotype was seen in all six
individuals for markers D12S1620, D12S361, D12S347, D12S270,
D12S390, D12S96, D12S398, D12S359, and D12S325 spanning
the type II keratin cluster (Fig 3). No linkage was seen for
microsatellite markers mapping to 17q12±q21.
Identi®cation of a novel splice site mutation in the 2B rod
domain Having shown a common haplotype across the type II
keratin cluster on 12q13 in all affected individuals investigated from
pedigree 1, we carried out mutation analysis of the type II keratin,
KRT1. Mutations in KRT1 have previously been associated with
NEPPK and BCIE. KRT1 is expressed in the suprabasal layers of
both palmoplantar and interfollicular epidermis. As discrepancies
had previously been detected in the KRT1 genomic sequence
(GenBank accession no. M77890), the gene was resequenced
(GenBank accession no. AF304164) and primers were designed to
amplify all exons (Table I).
Using PCR, each exon of KRT1 was ampli®ed from genomic
DNA of affected family members from pedigree 1. These PCR
products were then directly sequenced. Affected individuals
showed a single base substitution G±A in the exon 6 splice donor
site, G4134A (with reference to GenBank accession no. AF304164)
(Fig 4a).
Two other families with diffuse PPK, from a similar region of
Scotland, were screened and shown to harbour the same mutation.
Genotyping of an affected individual in pedigree 2 showed the
same genotype as in pedigree 1. This was not seen in an unaffected
individual from the same pedigree. In pedigree 3, this common
genotype only extended to D12S96, KRT1 maps between D12S96
and D12S390 (Table II). These data suggest that all three families
may indeed have the same ancestral mutation. We were unable to
obtain enough samples for haplotype analysis in these families,
however. This variant was not found in 50 unrelated unaffected
individuals. Also no mutation was found in KRT1 in two other
families with diffuse PPK. The absence of a KRT9 mutation in the
helix initiation and termination regions in these families further
suggests heterogeneity in the diffuse PPKs; however, more
investigations need to be carried out.
Prediction of the effect of the abolition of this splice site was
made using a splice predictor program (http://genomic.sanger.-
ac.uk/gf/gf.html). This gave a potential splice site 54 bases
downstream of the mutation with a probability of 0.81, compared
with a probability of 0.90 for the wild type splice site. To con®rm
the effect of this splice site mutation on the KRT1 mRNA, RT-
PCR was performed on total RNA extracted from a skin biopsy
taken from an affected individual. Using primers spanning exons 2±
7, two different sized alleles were ampli®ed in the affected
individual, which were subsequently subcloned and sequenced.
This revealed the utilization of the predicted in-frame splice site
(Fig 4b, c). Sequencing of further clones did not show the use of
any other splice sites. This mutation results in the insertion of 18
residues into the 2B rod domain (Fig 4d).
DISCUSSION
The novel mutation described results in the insertion of 18 amino
acids into the rod 2B domain of the protein, which could disrupt
the heptad repeat structure of the rod. This may have a detrimental
Figure 4. Identi®cation of the G4134A mutation in keratin 1 and
its effect on KRT1 mRNA. (a) Sequencing of keratin 1 revealed a
heterozygous G±A substitution in the exon 6 splice donor site. (b)
Alignment of cDNA sequence from an affected individual compared to
normal; the mutation leads to the insertion of 54 nucleotides. (c)
Schematic representation of abnormal splicing of exon 6 of KRT1,
showing the mutated splice site and new utilized splice site. (d) Eighteen
amino acids are inserted into the 2B rod domain of the keratin 1
molecule.
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effect on the function of the rod domain, which is predicted to be
important in intermediate ®lament assembly and stability.
Most previously described dominant KRT1 mutations result in
BCIE, also known as epidermolytic hyperkeratosis (Cheng et al,
1992; Chipev et al, 1992; Rothnagel et al, 1992). In BCIE lesions
usually appear within the ®rst year of life as blistering, erythroderma
that improves with age, and hyperkeratosis that generally persists
and can deteriorate. Histologically, epidermolysis is seen in
suprabasal cells with keratin clumping. This disorder can also be
due to mutations in KRT10, but palmoplantar involvement is
reported to occur more often in the KRT1 form (DiGiovanna and
Bale, 1994).
The phenotype in these families is distinct from BCIE as they
lack the generalized hyperkeratosis distributed over the entire body.
Hyperkeratosis is restricted to the palmoplantar surfaces in all but
one of the patients examined. This milder phenotype is re¯ected in
the histologic ®ndings, with only infrequent focal epidermolysis in
the upper spinous layer, instead of the widespread epidermolysis of
suprabasal cells common to BCIE.
The majority of mutations in KRT1 have been found in either
the helix initiation or termination sequence of the rod domain.
These regions are highly conserved among all keratins and other
intermediate ®lament proteins. These sites are preferentially
mutated in other keratin disorders, possibly occurring by CpG
methylation and deamination, such as keratin 5 and 14 in Dowling±
Meara epidermolysis bullosa simplex. Mutations in these regions
tend to result in a more severe disease phenotype (Letai et al, 1992).
Speci®c mutations in the helix termination sequence of keratin 1,
however, are capable of causing distinct disorders, such as
polycyclic erythematous (Michael et al, 1999) and psoriasiform
lesions (Sybert et al, 1999) in conjunction with epidermolytic
palmoplantar keratoderma.
A mutation in the V1 subdomain of KRT1, however, results in a
distinct phenotype, being associated with NEPPK and limited
hyperkeratosis of the areola, umbilicus, and knuckle pads of the
dorsal aspects of the ®nger joints. This mutation changes residue
lysine-72 to isoleucine, which is found in a highly conserved 22
residue sequence present in all type II keratins except KRT7 and
KRT8 (Kimonis et al, 1994). This region has been shown to be
essential for keratin ®lament attachment to the corni®ed cell
envelope (Candi et al, 1998). A mutation in the L12 linker domain
of the rod results in an atypically mild form of BCIE (Kremer et al,
1998).
This study supports the ®ndings that mutations more central in
the rod domain of keratin 1 do not disrupt the function of ®lament
assembly and stability as much as those in the helix initiation and
termination sequence. It also con®rms that mutations in keratin 1
can cause a wide range of phenotypes other than classical BCIE,
including PPK without obvious epidermolysis.
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Table II. Genotype of individuals in a further two families
at 12q13
Microsatellite marker Pedigree 1a
Pedigree 2b
Pedigree 3b
Affected Unaffected Affected
D12S347 3 3 3 2 2 1 2
D12S270 2 2 3 3 3 3 2
D12S390 3 3 2 2 2 1 2
D12S96 2 2 1 1 2 2 1
D12S398 2 2 2 2 2 2 1
D12S359 5 5 4 1 3 5 3
D12S325 4 4 1 1 3 4 1
aCommon haplotype seen in Fig 1.
bAlleles shared with pedigree 1 shown in bold.
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